» Articles » PMID: 27553208

Determinants of Change in the Cost-effectiveness Threshold

Overview
Publisher Sage Publications
Date 2016 Aug 25
PMID 27553208
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The cost-effectiveness threshold in health care systems with a constrained budget should be determined by the cost-effectiveness of displacing health care services to fund new interventions. Using comparative statics, we review some potential determinants of the threshold, including the budget for health care, the demand for existing health care interventions, the technical efficiency of existing interventions, and the development of new health technologies. We consider the anticipated direction of impact that would affect the threshold following a change in each of these determinants. Where the health care system is technically efficient, an increase in the health care budget unambiguously raises the threshold, whereas an increase in the demand for existing, non-marginal health interventions unambiguously lowers the threshold. Improvements in the technical efficiency of existing interventions may raise or lower the threshold, depending on the cause of the improvement in efficiency, whether the intervention is already funded, and, if so, whether it is marginal. New technologies may also raise or lower the threshold, depending on whether the new technology is a substitute for an existing technology and, again, whether the existing technology is marginal. Our analysis permits health economists and decision makers to assess if and in what direction the threshold may change over time. This matters, as threshold changes impact the cost-effectiveness of interventions that require decisions now but have costs and effects that fall in future periods.

Citing Articles

Cost-Effectiveness Analysis of Multiple Micronutrient Supplementation (MMS) Compared to Iron Folic Acid (IFA) in Pregnancy: A Systematic Review.

Alfiani F, Utami A, Zakiyah N, Daud N, Suwantika A, Puspitasari I Int J Womens Health. 2025; 17:639-649.

PMID: 40070683 PMC: 11894431. DOI: 10.2147/IJWH.S489159.


Reply to Comment on "A Framework for Fair Pricing of Medicines".

Paulden M Pharmacoeconomics. 2024; 42(5):607-609.

PMID: 38478252 DOI: 10.1007/s40273-024-01369-9.


A Framework for the Fair Pricing of Medicines.

Paulden M Pharmacoeconomics. 2023; 42(2):145-164.

PMID: 38066357 PMC: 10810971. DOI: 10.1007/s40273-023-01325-z.


Cost-effectiveness thresholds or decision-making threshold: a novel perspective.

Sun L, Peng X, Li S, Huang Z Cost Eff Resour Alloc. 2023; 21(1):72.

PMID: 37789326 PMC: 10548628. DOI: 10.1186/s12962-023-00472-6.


A Review of the Current Status of G6PD Deficiency Testing to Guide Radical Cure Treatment for Vivax Malaria.

Sadhewa A, Cassidy-Seyoum S, Acharya S, Devine A, Price R, Mwaura M Pathogens. 2023; 12(5).

PMID: 37242320 PMC: 10220632. DOI: 10.3390/pathogens12050650.